← Patent-cliff monitor Loss of exclusivity March 2044 latest FDA-listed patent expiry
Company Crinetics Pharmaceuticals
Drug detail Brand name PALSONIFY Active ingredient PALTUSOTINE HYDROCHLORIDE Strength EQ 30MG BASE Dosage form TABLET Route ORAL Modality Small molecule FDA approval September 2025 Marketing status RX
Listed patents Patent Expires Type 12208092 March 2044 use U-4282 11266641 September 2041 product 11957674 September 2041 use U-4283 10464918 January 2039 substance 10875839 July 2037 use U-4283 10597377 July 2037 substance, product 10351547 July 2037 substance, product 9896432 July 2037 substance, product 11414397 July 2037 substance, product
Regulatory exclusivity Code Expires ODE-537 September 2032 NCE September 2030
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.